China grants market approval for recombinant COVID-19 vaccine

CGTN published this video item, entitled “China grants market approval for recombinant COVID-19 vaccine” – below is their description.

For more:

China’s drug regulator the National Medical Products Administration approved on Thursday the registration application of a domestically produced recombinant COVID-19 vaccine. Led by Chen Wei, a researcher at the Academy of Military Sciences, a team developed a vaccine with the modified defective adenovirus as the vector. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase III trials.

CGTN YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

  • How opera singers in Britain treat long COVID patients | Focus on Europe
  • How COVID medical waste is worsening Gaza’s environmental crisis
  • Pandemic is both a ‘black swan’ and accelerator for AI industry
  • Londoners swarm Soho on the first Saturday after lockdown eased
  • US COVID-19: Parents threaten to sue officials over schools’ closure
  • Leave a Comment